tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Smith & Nephew Releases Six-Monthly Block Listing Return

Story Highlights
  • Smith & Nephew specializes in medical devices for orthopedics and wound management.
  • The company reported its six-monthly block listing return, detailing share scheme statuses.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
Smith & Nephew Releases Six-Monthly Block Listing Return

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

An update from Smith & Nephew Snats ( (SNN) ) is now available.

On October 16, 2025, Smith & Nephew plc released its six-monthly block listing return, detailing the status of various share schemes from February 1 to July 31, 2025. The report highlights that the Global Share Plan 2010 saw 206 securities issued, leaving 3,756 unallotted, while the Global Share Plan 2020 issued 5,758 securities, with 403,258 remaining unallotted. Other schemes, such as the Smith & Nephew ShareSave Plan and International ShareSave Plan, reported no new issuances, maintaining their previous balances. This update provides stakeholders with insights into the company’s equity distribution and potential future financial strategies.

The most recent analyst rating on (SNN) stock is a Hold with a $37.50 price target. To see the full list of analyst forecasts on Smith & Nephew Snats stock, see the SNN Stock Forecast page.

Spark’s Take on SNN Stock

According to Spark, TipRanks’ AI Analyst, SNN is a Outperform.

Smith & Nephew Snats shows strong financial performance with robust revenue and profit growth, which is the most significant factor in its stock score. The earnings call provided positive insights into future growth, despite some challenges in emerging markets and potential tariff impacts. The technical analysis indicates weak momentum, and the stock’s valuation is relatively high, which slightly offsets the overall positive outlook.

To see Spark’s full report on SNN stock, click here.

More about Smith & Nephew Snats

Smith & Nephew plc is a leading company in the medical technology industry, specializing in the development and manufacturing of advanced medical devices. The company focuses on providing innovative solutions in orthopedics, sports medicine, and wound management, aiming to improve patient outcomes and enhance healthcare delivery globally.

Average Trading Volume: 781,130

Technical Sentiment Signal: Buy

Current Market Cap: $15.05B

Learn more about SNN stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1